Every Atlantic Canadian Child, Equally Protected

Pneumonia Awareness Consortium
National Child Day | November 20, 2026

Closing the Gap in Pediatric Pneumococcal Protection

A position statement calling for equitable pneumococcal vaccine protection for children in Nova Scotia, New Brunswick, Prince Edward Island and Newfoundland and Labrador.

Every child deserves access to strong, evidence-based protection against serious pneumococcal disease, regardless of where they live.

The Issue

A Child's Protection Shouldn't Depend on Their Postal Code.

Pneumococcal disease can cause meningitis, bloodstream infections and pneumonia. Young children are among those at greatest risk.

Atlantic Canada
PCV15
15-valent pneumococcal conjugate vaccine
Routine infant immunization

Currently offered in Nova Scotia, New Brunswick, Prince Edward Island and Newfoundland and Labrador. It provides protection targeting the 15 serotypes it covers.

The National Advisory Committee on Immunization considers both PCV15 and PCV20 appropriate for healthy children and expects PCV20 to have a larger impact on invasive pneumococcal disease.

The Atlantic provinces have established strong infant immunization programs, offering free pneumococcal vaccination to every baby and adopting newer vaccines following national guidance. Expanding routine access to PCV20 would build on these foundations.

Understanding the Urgency

Why It Matters Now

Changing disease patterns, antibiotic resistance and differences in vaccine coverage highlight the importance of continued prevention efforts.

01

Pneumococcal Disease Is Back

Pneumococcal disease has returned to pre-pandemic levels. Rates in children aged one to four reached a ten-year high in 2022.

02

Antibiotic Resistance Is Rising

Across all ages, multidrug-resistant invasive pneumococcal disease rose from 8.4% to 13.2% of tested isolates between 2019 and 2023.

03

Some Children Face Greater Risks

Certain conditions increase a child's risk of severe infection. These conditions are not always diagnosed when vaccination begins, making broader coverage from the first dose especially important.

04

Prevention Benefits Communities

Preventing severe disease can reduce emergency visits, hospital stays, antibiotic use and time away from work for parents and caregivers.

A Call for Coordinated Action

Our Questions for Atlantic Governments

We respectfully ask the Ministers of Health and Chief Medical Officers of Health of the four Atlantic provinces to consider the following:

1

Broader Access

Atlantic provincial governments should broaden access to PCV20 to every infant in the routine immunization program.

2

Regional Collaboration

Atlantic provincial governments should act together as a region, sharing implementation tools, public messaging, and clinician training.

3

Protection for Higher-Risk Children

Atlantic provincial governments should ensure children at higher risk receive PCV20 according to NACI’s recommended four-dose schedule.

4

Measuring Progress

Atlantic provincial governments should measure, and report results each year, starting with vaccine coverage and serotype-specific invasive pneumococcal disease in young children.

Information for Families

A Message for Parents

Keep Your Child's Vaccines on Schedule.

The vaccine Atlantic infants receive today protects well against the 15 serotypes it covers.

If you have questions about your child's vaccinations, speak with your health-care provider or local public health office.

Help Raise Awareness

Share the Statement

Help us make sure every family in Atlantic Canada knows about this difference in vaccine coverage.

Read the full position statement and share it with your community.

Share This Page

About Us

Pneumonia Awareness Consortium

The Pneumonia Awareness Consortium is a collaboration of health advocates, including non-governmental organizations, dedicated to spreading evidence-based knowledge and preventing respiratory diseases through education, outreach and community support.

Learn More About the Consortium ↗
Secretariat Support

Society for Intelligence Management

The Society for Intelligence Management (SIM) is an independent association promoting evidence-based knowledge translation, education, communication and informed decision-making.

SIM provides secretariat support to the Pneumonia Awareness Consortium.

Learn More About SIM ↗

This statement was made possible through financial support from Pfizer Canada ULC.

Take Action Today

Don’t wait—equip yourself with the information you need to protect your family and community. Download our resources now and join us in the fight against Pneumonia. Together, we can make a difference.

Translate »
Contact Us